论文部分内容阅读
目的探索一种适合鼻咽癌首程治疗后颈淋巴结残留或复发的再治疗方案,为这类患者的临床治疗提供参考。方法总结46例鼻咽癌患者首程治疗后颈淋巴结残留或复发的再治疗资料,将不同的治疗方案与疗效之间的关系应用统计学进行分层分析。结果 46例患者5年生存率为59%。手术再治疗组术后5年生存率为72%,放、化疗组再治疗后5年生存率为26%,差异有显著的统计学意义。结论鼻咽癌首程治疗后颈淋巴结残留或复发的再治疗,手术是首选的治疗方式,能显著提高生存率。
Objective To explore a re-treatment protocol for residual or recurrent cervical lymph node after nasopharyngeal carcinoma (NPC) for the first course of treatment, and provide a reference for the clinical treatment of these patients. Methods The data of re-treatment of residual or recurrent cervical lymph nodes in 46 patients with nasopharyngeal carcinoma after first-stroke treatment were summarized. The relationship between different treatment regimens and therapeutic effects was stratified using statistical methods. Results The 5-year survival rate of 46 patients was 59%. Surgical re-treatment group 5-year survival rate was 72%, radiotherapy and chemotherapy group 5-year survival rate after re-treatment was 26%, the difference was statistically significant. Conclusion Re-treatment of residual or recurrence of cervical lymph node after nasopharyngeal carcinoma is the first course of treatment, surgery is the preferred treatment and can significantly improve the survival rate.